Priority Date: 31.08.11 (EP 20110179500)

METHOD FOR PREDICTING RISK OF HYPERTENSION ASSOCIATED WITH ANTI-ANGIOGENESIS THERAPY

  • Application ID: EP12750601
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Applicants

Research organisation logo small
Research Organisation
Research organisation logo small
Research Organisation
Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). F. Hoffmann-La Roche AG is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 31.08.2011 - Priority Date (EP 20110179500)
  • 07.03.2013 - Publication A1 (WO2013030168)
  • 09.07.2014 - Publication A1 (EP2751280)
  • 29.06.2016 - Publication B1 (EP2751280)

IPC Classification